Aldeyra Therapeutics
ALDX
$3.93
Share price
-0.25%
Change (1 day)
-58.76%
Change (1 year)
Categories
Aldeyra Therapeutics (ALDX) - P/B ratio
P/B ratio as of April 2024 : 1.95
According to Aldeyra Therapeutics
's latest financial reports the company has a price-to-book ratio of 1.95.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Aldeyra Therapeutics - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.72 | -36.14% |
| 2022-12-31 | 2.70 | 138.97% |
| 2021-12-31 | 1.13 | -74.76% |
| 2020-12-31 | 4.48 | 29.24% |
| 2019-12-31 | 3.46 | 37.69% |
| 2018-12-31 | 2.51 | -23.39% |
| 2017-12-31 | 3.28 | 5.63% |
| 2016-12-31 | 3.11 | 17.41% |
| 2015-12-31 | 2.65 | -58.61% |
| 2014-12-31 | 6.39 | |
| 2013-12-31 | N/A | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | 3.73 | 91.49% | 🇺🇸 USA |